ubmslateEN-logo-ubm

EN Mobile Logo

Search form

Topics:

Home

Type 2 Diabetes and Insulin: Physician Reluctance

Do you hesitate to initiate insulin therapy in type 2 diabetes patients? To understand barriers, researchers conducted a cross-sectional survey.

 

© Sherry Yates Young/Shutterstock.com

Recent Content

What role, if any, does ethnicity play in potential life years lost in patients with diabetes?

The device, initialized using only body mass, with no required data on usual insulin regimens, was compared to standard care with insulin pump and CGM.

Our December list includes new care guidelines for neuropathy, updates to oral medication recommendations, and long-term RYGB outcomes for adolescents.

This month’s roundup covers hip fracture risk, improvements in diabetes-associated risk assessment, and a model to calculate gestational diabetes risk.

Our blogger discusses potential issues your patients may face with self-monitoring of blood glucose and offers troubleshooting tips.

Is LADA a separate disease entity or does it lie on an autoimmune continuum as a slowly progressive form of T1DM?

How do you treat patients with type 2 diabetes unable to achieve glycemic control with either oral treatment or basal insulin?

By clicking Accept, you agree to become a member of the UBM Medica Community.